Abstract:OBJECTIVE To observe the effect of DNA Sema4D gene silencing by RNA interfering on the proliferation, migration and invasion of human ovarian cancer SKOV3 cells, and to study the effect of pshRNASema4D on the growth of SKOV3 cells in transplanted tumor in nude mice. METHODS Recombinant plasmid pshRNASema4D-A, B and C were respectively transfected into SKOV3 cells by lipofetamine 2000, while cells transfected by plasmid vector pcDNA3.1 and cells untreated as control groups. RT-PCR was adopted to select the recombinant plasmid which showed the most optimal inhibition effect. RT-PCR and Western blot were used to detected the mRNA and protein expression of Sema4D in SKOV3 cells tranfected for 24, 48 and 72 hours. MTT assay was used to investigate the proliferation of the SKOV3 cells after trasnsfection. Transwell cell migration and invasion assays were used to investigate the migration and invasion abilities of the SKOV3 cells after trasnsfection. Human ovarian cancer model was established in nude mice, and the nude mice were treated with pshRNASema4D-B once every 3 days for 3 weeks. The bulk of the transplanted tumor was measured. RESULTS Three Sema4D-targeted short hairpin RNA (shRNA) A, B and C were successfully inserted into the plasmid vector pshRNA, and the coding sequences of the obtained shRNA were consistent with the designed fragment. The results indicated that both recombinant plasmid pshRNASema4D-A and B could effectively knock down the expression of Sema4D gene in human ovarian cancer cells, of which pshRNASema4D-B was the better choice, while no effect of pshRNASema4D-C was seen. RT-PCR results showed that the relative mRNA expression of Sema4D gene in SKOV3 cells transfected with pshRNA-Sema4D for 24, 48 and 72 hours were 0.401 ± 0.051, 0.120 ± 0.035 and 0.014 ± 0.015, respectively, which were significantly lower than that in SKOV3 cells transfected by empty vector and non-transfected cells at 72 hours after transfection. (0.521 ± 0.019, 0.536 ± 0.040,respectively, P < 0.05). The Westen blot analysis manifested that the relative expression of Sema4D protein of SKOV3 cells transfected by pshRNASema4D for 24, 48 and 72 hours were 0.196 ± 0.023, 0.074 ± 0.015 and 0.040 ± 0.014, respectively, which were significantly lower than that in SKOV3 cells transfected by empty vector and non-transfected cells at 72 hours after transfection. (0.275 ± 0.009, 0.282 ± 0.015, respectively, P < 0.05). Comparing with the empty vector-transfected and non-transfected cells, the proliferation, invasion and migration ability of SKOV3 cells transfected with pshRNA-Sema4D were obviously weakened. The pshRNASema4D-B significantly suppressed the growth of the SKOV3 cells-transplanted tumors in nude mice, and the IR (inhibitory rate) of pshRNASema 4D-B group was (61.0 ± 3.3)% (P < 0.05). CONCLUSIONS Sema4D can be successfully silenced by RNA interfering in human ovarian cancer SKOV3 cells. Downregulation of Sema4D can inhibit the proliferation, migration and invasion of ovarian cancer cells. The pshRNASema4D can significantly suppress the growth in transplanted tumor of human ovary cancer in nude mice. Sema4D may become a candidate gene of gene therapy of human ovarian cancer.

Inhibitory Effect of STAT3 Silenced with RNAi on Growth of Human Ovarian Cancer SKOV3 Cell Transplanted Tumor in Nude Mice

Knockdown of Stat3 Expression by RNAi Inhibits in Vitro Growth of Human Ovarian Cancer.

Knockdown of STAT3 Expression in SKOV3 Cells by Biodegradable Sirna–plga/cso Conjugate Micelles

Efficient Inhibition of Intraperitoneal Ovarian Cancer Growth in Nude Mice by Liposomal Delivery of Short Hairpin RNA Against STAT3

Proliferation suppression and apoptosis of ovarian carcinoma cells induced by small interfering RNA against vascular endothelial growth factor.

Induction of Human Ovarian Carcinoma Cell Line SKVO-3apoptosis by Sirna Through Targeting to Survivin

Effect of Silencing STAT3 Gene on Growth of Human Pancreatic Cancer Cells in Vivo

RNA Interference-Mediated Silencing of the Phosphatidylinositol 3-Kinase Catalytic Subunit Attenuates Growth of Human Ovarian Cancer Cells in Vitroand in Vivo.

RNA interference targeting EGFR on proliferation of human ovarian carcinoma cell line SKOV_3

Knockdown of Stat3 Expression Using RNAi Inhibits Growth of Laryngeal Tumors in Vivo.

Suppression of Rna Interference on Expression of C-Myc of Skov3 Ovarian Carcinoma Cell Line

Studies the Biological Behavior of Ovarian Cancer Cell Line SKOV3 Silenced Her-2 by RNAi with Animal Experiment

Study on the Inhibition of Small interfering RNA Targeting Osteopontin in the Human Ovarian Carcinoma SKOV3 Cells

Inhibition Effect of Silencing EGFR Gene by RNAi on Tumorigenesis of Xenograft Tumor of Ovarian Cancer

Effect of STAT3 Gene Silencing on Xenografts in Human Pancreatic Cancer SW1990 in Nude Mice

Effect of Inhibiting STAT3 Gene on Growth of Human Pancreatic Cancer Cells in Vitro

Effects of RNAi on HER2/neu Gene and Proliferation of SK-OV-3 Ovarian Cancer Cells in Vitro

VEGF-targeted short hairpin RNA inhibits intraperitoneal ovarian cancer growth in nude mice.

Plasmid-based STAT3-siRNA Efficiently Inhibits Breast Tumor Growth and Metastasis in Mice.

Down-regulation of STAT3 Expression by Vector-Based Small Interfering RNA Inhibits Pancreatic Cancer Growth

[Effect of Semaphorin4d Gene Silencing on Malignant Behavior of Human Ovarian Cancer SKOV3 Cells].